These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Author: Neumann E.
    Journal: Wien Klin Wochenschr; 1981 Feb 20; 93(4):134-7. PubMed ID: 6895134.
    Abstract:
    50 patients with Hodgkin's disease were treated with MOPP chemotherapy. Therapeutic success depended on previous treatment, stage of disease and histological subtype. Complete remission was achieved in 56%, partial remission in 28% and no response in 16% of the patients. None of the non-responders survived for longer than 2 years. Patients demonstrating partial remissions showed a median survival time of 3 years, whereas 23 out of 28 patients with complete remissions are still alive after 2 to 7 years. The median remission duration in cases of complete remission has not yet been reached, but would, at present, be not less than 48 months, with no patient at risk. 7 out of 9 patients who relapsed are on alternative treatment (ABVD, TNI) and doing well, the 2 remaining patients died in the course of the disease.
    [Abstract] [Full Text] [Related] [New Search]